person
Philippe F.
- Country
- France
- Department
- Oncology
Research Overview
assignment
34
Clinical Trials ·
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase 1 Open-Label Study of CTPS1 Inhibitor STP938 in Advanced Solid Tumors and CTPS2 Null Ovarian Cancer
- Phase I Study of OKI-219 Monotherapy and in Combination with Endocrine or HER2-Targeted Therapy in Advanced Solid Tumors and Breast Cancer
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
264
Sites with multiple studies
Has run more than one trial at 264 of 454 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating gynecologic malignancies, with particular focus on ovarian cancer, endometrial cancer, and cervical cancer. Their research encompasses both early-stage and advanced disease states.
- High-grade serous ovarian cancer management
- Advanced cervical cancer treatment approaches
- Endometrial cancer therapeutic strategies
Targeted Therapies
The investigator focuses on implementing novel targeted therapeutic approaches, including immunotherapy and maintenance treatments for gynecologic cancers.
- PARP inhibitor therapy
- Immune checkpoint inhibitors
- Antibody-drug conjugates
Precision Medicine
Research interests include molecular-based treatment selection and biomarker-driven therapy for gynecologic cancers.
- Molecular profiling in treatment selection
- Personalized medicine approaches
- Combination therapy strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.